Results 161 to 170 of about 499,568 (198)

Prognostic models in end stage liver disease

Best Practice & Research Clinical Gastroenterology, 2023
Cirrhosis is a major cause of death worldwide, and is associated with significant health care costs. Even if milestones have been recently reached in understanding and managing end-stage liver disease (ESLD), the disease course remains somewhat difficult to prognosticate.
Ferrarese, A, Bucci, M, Zanetto, A, Senzolo, M, Germani, G, Gambato, M, Russo, F P, Burra, P   +7 more
openaire   +2 more sources

Mortality in patients with end‐stage liver disease above model for end‐stage liver disease 3.0 of 40

Hepatology, 2023
Background and Aims: Since the implementation of the model for end‐stage liver disease (MELD) score to determine waitlist priority for liver transplant (LT) in 2002, the score has been capped at 40. Recently, the MELD 3.0 score was proposed to improve upon MELD‐Na. Here, we examine waitlist mortality and LT outcomes in patients
W. Ray Kim, Ajitha Mannalithara, Paul Y. Kwo, C. Andrew Bonham, Allison Kwong   +4 more
openaire   +2 more sources

Liver transplantation in the era of model for end‐stage liver disease

Liver International, 2004
Abstract: Liver transplantation is challenged by organ shortage and prolonged waiting list time. The goal of the ideal organ allocation system is to transplant individuals least likely to survive without a liver transplantation, and maintain appropriate rates of postoperative survival.
Victor S, Wang, Sammy, Saab
openaire   +2 more sources

A prognostic model for patients with end-stage liver disease

Gastroenterology, 1997
Survival of patients with end-stage liver disease is variable and difficult to predict. A two-phase prospective cohort study was conducted at five teaching hospitals to develop and evaluate a model for prediction of death.Five hundred thirty-eight hospitalized patients with a history of chronic liver disease and two or more signs of decompensation were
G S, Cooper, P, Bellamy, N V, Dawson, N, Desbiens, W J, Fulkerson, L, Goldman, L M, Quinn, T, Speroff, C S, Landefeld   +8 more
openaire   +2 more sources

Model for end-stage liver disease (MELD) exception for polycystic liver disease

Liver Transplantation, 2006
Polycystic liver disease (PLD) is commonly associated with polycystic kidney disease, but is unaccompanied by renal cysts in 10% of cases. Symptomatic PLD is mainly limited to adults and rarely, if ever, presents in childhood. There is currently no effective medical therapy for PLD. Most patients who have PLD require no medical or surgical intervention.
Luis, Arrazola, Dilip, Moonka, Robert G, Gish, Gregory T, Everson   +3 more
openaire   +2 more sources

Mind the Model for End-Stage Liver Disease: Model for End-Stage Liver Disease Score as an Indicator of Hemoderivate Transfusion and Survival in Liver Transplantation

Transplantation Proceedings, 2015
The scarcity of liver donors has increased the necessity to closely select recipients to improve liver transplantation outcomes. If we were able to recognize those recipients with the best outcomes, then this could result in a better and more accurate selection of our donors. Hemoderivate transfusion is one of the main important factors to analyse.
I J, Alonso, O C, Maestro, N F, Gómez, R S, Mateos, A M, Quinto, F C, Molero, A M, Municio, J C, Pulido, C L, Segurola, C J, Romero   +9 more
openaire   +2 more sources

A Model to Predict Survival in Patients With End–Stage Liver Disease

Hepatology, 2001
A recent mandate emphasizes severity of liver disease to determine priorities in allocating organs for liver transplantation and necessitates a disease severity index based on generalizable, verifiable, and easily obtained variables.
P S, Kamath, R H, Wiesner, M, Malinchoc, W, Kremers, T M, Therneau, C L, Kosberg, G, D'Amico, E R, Dickson, W R, Kim   +8 more
openaire   +2 more sources

Clinically Relevant Differences in the Model for End-Stage Liver Disease and Model for End-Stage Liver Disease-Sodium Scores

Liver Transplantation, 2009
With interest, we read the article by Xiol et al. regarding differences in serum measurements between different laboratories and their influence on the Model for End-Stage Liver Disease (MELD) and the Model for End-Stage Liver Disease incorporating serum sodium (MELD-Na).
Rhiana Garritsen, Andrei Tintu, Herold Metselaar, Geert Kazemier   +3 more
openaire   +1 more source

The Model for End-stage Liver Disease Comes of Age

Clinics in Liver Disease, 2007
The care of patients who have chronic liver disease has evolved considerably since the Model for End-stage Liver Disease (MELD) was first described 6 years ago. This article traces the progress in liver allocation and clinical liver disease research that includes the MELD score and highlights the management of areas in which MELD and the principles ...
openaire   +2 more sources

Model for End-Stage Liver Disease and liver cirrhosis-related complications

Hepatology International, 2012
The Model for End-Stage Liver Disease (MELD) score has gained wide acceptance for predicting survival in patients undergoing liver transplantation. The strength of this score remains in the mathematical formula derived from a multivariate Cox regression analysis; it is a continuous scale and lacks a ceiling or a floor effect with a wide range of ...
Luis Calzadilla, Bertot, Eduardo Vilar, Gomez, Linnet Alonso, Almeida, Enrique Arus, Soler, Luis Blanco, Perez   +4 more
openaire   +2 more sources